Predict your next investment

Venture Capital
arboretumvc.com

See what CB Insights has to offer

Investments

159

Portfolio Exits

27

Funds

5

Partners & Customers

1

Service Providers

1

About Arboretum Ventures

Arboretum Ventures is an early-stage venture capital firm specializing in the healthcare sector. Tge firm focuses primarily on investments in medical technology and healthcare services. Arboretum invests throughout the United States, with a special interest in the Midwest region. Founded in 2002 and located in Ann Arbor, Michigan, Arboretum currently manages $95 million in capital.

Arboretum Ventures Headquarters Location

303 Detroit Street Suite 301

Ann Arbor, Michigan, 48104,

United States

734-998-3688

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Arboretum Ventures News

Arboretum Ventures to raise $250 million in new fund - Crain's Detroit Business

Jul 2, 2022

Business Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN

Arboretum Ventures Investments

159 Investments

Arboretum Ventures has made 159 investments. Their latest investment was in Enumera Molecular as part of their Series A on May 5, 2022.

CBI Logo

Arboretum Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/5/2022

Series A

Enumera Molecular

$12.5M

Yes

2

2/3/2022

Series B

Koya Medical

$26M

No

10

11/19/2021

Series B

ViaLase

$27.29M

Yes

1

10/12/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

9/15/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/5/2022

2/3/2022

11/19/2021

10/12/2021

9/15/2021

Round

Series A

Series B

Series B

Series B

Series C

Company

Enumera Molecular

Koya Medical

ViaLase

Subscribe to see more

Subscribe to see more

Amount

$12.5M

$26M

$27.29M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

1

10

10

Arboretum Ventures Portfolio Exits

27 Portfolio Exits

Arboretum Ventures has 27 portfolio exits. Their latest portfolio exit was Pear Therapeutics on December 06, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/6/2021

Reverse Merger

$99M

8

11/16/2021

Acquired

$99M

3

8/6/2021

Acq - Pending

$99M

15

6/30/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

3/11/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/6/2021

11/16/2021

8/6/2021

6/30/2021

3/11/2021

Exit

Reverse Merger

Acquired

Acq - Pending

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

8

3

15

10

10

Arboretum Ventures Fund History

5 Fund Histories

Arboretum Ventures has 5 funds, including Arboretum Ventures V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/18/2019

Arboretum Ventures V

Early-Stage Venture Capital

Closed

$250M

2

9/15/2015

Arboretum Ventures IV

Subscribe to see more

Subscribe to see more

$99M

10

9/8/2011

Arboretum Ventures III LP

Subscribe to see more

Subscribe to see more

$99M

10

2/12/2009

Arboretum Ventures II LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2003

Arboretum Ventures I

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

6/18/2019

9/15/2015

9/8/2011

2/12/2009

12/31/2003

Fund

Arboretum Ventures V

Arboretum Ventures IV

Arboretum Ventures III LP

Arboretum Ventures II LP

Arboretum Ventures I

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$250M

$99M

$99M

$99M

$99M

Sources

2

10

10

10

10

Arboretum Ventures Partners & Customers

1 Partners and customers

Arboretum Ventures has 1 strategic partners and customers. Arboretum Ventures recently partnered with HealthMedia on July 7, 2005.

Date

Type

Business Partner

Country

News Snippet

Sources

7/25/2005

Partner

United States

Arboretum Ventures Joins Existing Investors. You are here: Home / Chrysalis News / HealthMedia, Inc. Raises $2 Million of Growth Capital.

According to Tim Petersen , Arboretum Ventures Managing Partner , `` HealthMedia , Inc. 's custom solutions have proven clinically successful at improving health related behavior for the constituents of health plans and self-insured employers , and increasing prescribed regimen compliance and efficacy for pharmaceutical firms , medical device manufacturers , and disease management firms .

1

Date

7/25/2005

Type

Partner

Business Partner

Country

United States

News Snippet

Arboretum Ventures Joins Existing Investors. You are here: Home / Chrysalis News / HealthMedia, Inc. Raises $2 Million of Growth Capital.

According to Tim Petersen , Arboretum Ventures Managing Partner , `` HealthMedia , Inc. 's custom solutions have proven clinically successful at improving health related behavior for the constituents of health plans and self-insured employers , and increasing prescribed regimen compliance and efficacy for pharmaceutical firms , medical device manufacturers , and disease management firms .

Sources

1

Arboretum Ventures Service Providers

1 Service Provider

Arboretum Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Arboretum Ventures Team

11 Team Members

Arboretum Ventures has 11 team members, including current Founder, Managing Partner, Jan Garfinkle.

Name

Work History

Title

Status

Jan Garfinkle

Founder, Managing Partner

Current

Timothy B Petersen

Michigan Business Challenge

Founder, Managing Partner

Current

Timothy Peterson

Founder

Current

Ronald W. Dollens

Chief Executive Officer, President

Current

Dean Koch

Chief Executive Officer

Current

Name

Jan Garfinkle

Timothy B Petersen

Timothy Peterson

Ronald W. Dollens

Dean Koch

Work History

Michigan Business Challenge

Title

Founder, Managing Partner

Founder, Managing Partner

Founder

Chief Executive Officer, President

Chief Executive Officer

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.